Dendritic cells: Potential role in cancer therapy

Cytotechnology

Volumn 25, Issue 1-3, 1997, Pages 1-8

  Engleman, Edgar G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Dendritic cells; Idiotype; Immunotherapy; Malignant Lymphoma

Indexed keywords

EID: 0031407809     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007997918593     Document Type: Conference Paper

References (25)

1. Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR and Cheever MA (1995) Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 55: 1099.
2. Carroll WL, Thielemans K, Dilley J and Levy R (1986) Mouse × human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods 89: 61.
3. Caux C, Dezutter DC, Schmitt C and Banchereau J (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360: 258.
4. Fagnoni FF, Takamizawa M, Godfrey WR, Rivas A, Azuma M, Okumura K and Engleman EG (1995) Role of B70/B7-2 in CD4+ T cell immune responses induced by dendritic cells. Immunology 85: 467-474.
5. Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299.
6. Hsu FJ, Kwak L, Campbell M, Liles T, Czerwinski D, Hart S, Syrengelas A, Miller R and Levy R (1993) Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann NY Acad Sci 690: 385-387.
7. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG and Levy R (1996) Vaccination of patients with B cell lymphoma using autologous antigen pulsed dendritic cells. Nature Medicine 2: 52.
8. Kim D, Mitchell D, Brockstedt D, Fong L, Nolan G, Fathman CG, Engleman E and Rothbard J, Introduction of soluble proteins into both MHC class I and II pathways by conjugation to a HIV tat peptide. (submitted for publication).
9. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA and Levy R (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327: 1209-1215.
10. Levy R, Hatzubia A, Brown S, Maloney D and Dilley J (1982) Immunoglobulin idiotype: A tumor-specific antigen for human B-cell lymphomas. In: Malignant Lymphomas. New York: Academic Press, Ch. 5.
11. Lynch RG, Rohrer JW, Odermatt B, Gebel HM, Autry JR and Hoover RG (1979) Immunoregulation of murine myeloma cell growth and differentiation: A monoclonal model of B cell differentiation. Immunol Rev 48: 45-80.
12. Maloney DG, Kaminski MS, Burowski D, Haimovich J and Levy R (1985) Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: Characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4: 191.
13. Markowicz S and Engleman EG (1990) Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 85: 955-961.
14. Mehta-Damani A, Markowicz S and Engleman EG (1994) Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol 153: 996-1003.
15. Mehta-Damani A, Markowicz S and Engleman EG (1995) Antigen specific CD4+ T cells derived from naive precursors. Eur J Immunol 25: 1206-11.
16. Nestle F and Nickoloff BJ (1994) Role of dendritic cells in benign and malignant lymphocytic infiltrates of the skin. Dermatol Clinics 12:271.
17. Nixon DF and McMichael AJ (1991) Cytotoxic T cell recognition of HIV proteins and peptides. AIDS 5: 1045-59.
18. Paglia P, Chiodoni M, Rodolfo M and Colombo MP (1996) Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183: 317.
19. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM and Schuler G (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180: 83.
20. Sallusto F and Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109.
21. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9: 271.
22. Takamizawa M, Fagnoni F, Mehta-Damani A, Rivas A and Engleman EG (1995) Cellular and molecular basis of human γδ T cell activation. Role of accessory molecules in alloactivation. J Clin Invest 95: 296-303.
23. Takamizawa M, Rivas A, Fagnoni F, Benike C, Kosek J, Hyakawa H and Engleman EG (1997) Dendritic cells that process and present nominal antigens to naive T lymphocytes are derived from CD2+ precursors. J Immunol 158: 2134-2142.
24. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K (1990) Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 66: 2012.
25. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT and Storkus WJ (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183: 87.